Tan W, Lim L, Afsha N, Chan G, Ching C, Oguz G
PNAS Nexus. 2025; 4(2):pgae568.
PMID: 39990763
PMC: 11843648.
DOI: 10.1093/pnasnexus/pgae568.
Kanno H, Nakahara K, Yamada S, Fujii S, Murata H, Yamamoto T
J Kidney Cancer VHL. 2025; 11(4):39-47.
PMID: 39850947
PMC: 11756601.
DOI: 10.15586/jkcvhl.v11i4.355.
Kwon R, Kim H, Lee Y, Lee H, Lee S, Park E
Life (Basel). 2024; 14(11).
PMID: 39598242
PMC: 11595514.
DOI: 10.3390/life14111444.
Son S, Lee H, Kim J, Kwon R
Transl Cancer Res. 2024; 13(5):2282-2294.
PMID: 38881934
PMC: 11170499.
DOI: 10.21037/tcr-23-2286.
Zhang C, Zeng J, Ye C, Tian K, Xian Z
Transl Cancer Res. 2024; 13(1):150-172.
PMID: 38410230
PMC: 10894348.
DOI: 10.21037/tcr-23-1383.
HAGLR, A Long Non-coding RNA of Potential Tumor Suppressive Function in Clear Cell Renal Cell Carcinoma: Diagnostic and Prognostic Implications.
Bardhan A, Banerjee A, Pal D, Ghosh A
Mol Biotechnol. 2023; 66(12):3485-3497.
PMID: 37955777
DOI: 10.1007/s12033-023-00948-z.
Decreased zinc-fingers and homeoboxes family expression was associated with unfavorable outcomes and immune infiltration in lung adenocarcinoma.
Tao D, Tan J, Zhang N, Yang D, Jiang Y, Zhou W
Transl Cancer Res. 2023; 12(6):1422-1440.
PMID: 37434685
PMC: 10331706.
DOI: 10.21037/tcr-22-2793.
Zinc fingers and homeoboxes 2 inhibition could suppress the proliferation of ovarian cancer cells by apoptosis pathway.
Ding R, Shi H, Guo Y, Zeng W, Fan J
Clin Transl Oncol. 2023; 25(7):2116-2126.
PMID: 36746874
DOI: 10.1007/s12094-023-03090-z.
Zinc Fingers and Homeobox Family in Cancer: A Double-Edged Sword.
Bao Y, Zhang H, Han Z, Guo Y, Yang W
Int J Mol Sci. 2022; 23(19).
PMID: 36232466
PMC: 9570228.
DOI: 10.3390/ijms231911167.
Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy.
You Y, Hu F, Hu S
Oncol Lett. 2022; 24(1):224.
PMID: 35720472
PMC: 9185145.
DOI: 10.3892/ol.2022.13345.
Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer.
Zhu K, Liu X, Deng W, Wang G, Fu B
Hereditas. 2022; 159(1):13.
PMID: 35125116
PMC: 8819906.
DOI: 10.1186/s41065-021-00212-x.
Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation.
Igata T, Tanaka H, Etoh K, Hong S, Tani N, Koga T
PLoS One. 2022; 17(1):e0262488.
PMID: 35085309
PMC: 8794122.
DOI: 10.1371/journal.pone.0262488.
Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: a retrospective cohort study.
Kwon R, Park E, Lee S, Lee Y, Hwang C, Kim C
Lipids Health Dis. 2021; 20(1):104.
PMID: 34511128
PMC: 8436523.
DOI: 10.1186/s12944-021-01539-0.
A zinc finger protein gene signature enables bladder cancer treatment stratification.
Zhang J, Zhang C, Cao P, Zheng X, Yu B, Cao H
Aging (Albany NY). 2021; 13(9):13023-13038.
PMID: 33962398
PMC: 8148496.
DOI: 10.18632/aging.202984.
Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.
Cheng A, Guo X, Dai X, Wang Z
FEBS Open Bio. 2021; 11(6):1785-1798.
PMID: 33837660
PMC: 8167877.
DOI: 10.1002/2211-5463.13160.
Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia.
Maciel N, Filiu-Braga L, Neves F, Rego E, Lucena-Araujo A, Saldanha-Araujo F
Biomark Res. 2021; 9(1):10.
PMID: 33541423
PMC: 7863484.
DOI: 10.1186/s40364-021-00263-2.
Prognostic value and therapeutic implications of ZHX family member expression in human gastric cancer.
You Y, Bai F, Li H, Ma Y, Yao L, Hu J
Am J Transl Res. 2020; 12(7):3376-3388.
PMID: 32774706
PMC: 7407748.
Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma.
Guo T, Zambo K, Zamuner F, Ou T, Hopkins C, Kelley D
Epigenetics. 2020; 15(9):959-971.
PMID: 32164487
PMC: 7518675.
DOI: 10.1080/15592294.2020.1741757.
Host Transcription Factors in Hepatitis B Virus RNA Synthesis.
Turton K, Meier-Stephenson V, Badmalia M, Coffin C, Patel T
Viruses. 2020; 12(2).
PMID: 32019103
PMC: 7077322.
DOI: 10.3390/v12020160.
Bioinformatic profiling identifies a platinum-resistant-related risk signature for ovarian cancer.
Wu C, He L, Wei Q, Li Q, Jiang L, Zhao L
Cancer Med. 2019; 9(3):1242-1253.
PMID: 31856408
PMC: 6997076.
DOI: 10.1002/cam4.2692.